Cargando…
Suppression of Hepatic Bile Acid Synthesis by a non-tumorigenic FGF19 analogue Protects Mice from Fibrosis and Hepatocarcinogenesis
Critical regulation of bile acid (BA) pool size and composition occurs via an intensive molecular crosstalk between the liver and gut, orchestrated by the combined actions of the nuclear Farnesoid X receptor (FXR) and the enterokine fibroblast growth factor 19 (FGF19) with the final aim of reducing...
Autores principales: | Gadaleta, Raffaella Maria, Scialpi, Natasha, Peres, Claudia, Cariello, Marica, Ko, Brian, Luo, Jian, Porru, Emanuele, Roda, Aldo, Sabbà, Carlo, Moschetta, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249240/ https://www.ncbi.nlm.nih.gov/pubmed/30464200 http://dx.doi.org/10.1038/s41598-018-35496-z |
Ejemplares similares
-
Long-term Administration of Nuclear Bile Acid Receptor FXR Agonist Prevents Spontaneous Hepatocarcinogenesis in Abcb4(−/−) Mice
por: Cariello, Marica, et al.
Publicado: (2017) -
Corrigendum to ‘Fibroblast growth factor 19 modulates intestinal microbiota and inflammation in presence of farnesoid x receptor’: [EBioMedicine 54 (2020) 102719]
por: Gadaleta, Raffaella Maria, et al.
Publicado: (2020) -
Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor
por: Gadaleta, Raffaella Maria, et al.
Publicado: (2020) -
Total serum FGF-21 levels positively relate to visceral adiposity differently from its functional intact form
por: Crudele, Lucilla, et al.
Publicado: (2023) -
Intestinal FXR Activation via Transgenic Chimera or Chemical Agonism Prevents Colitis-Associated and Genetically-Induced Colon Cancer
por: Cariello, Marica, et al.
Publicado: (2022)